Available Until 6/18/2027
View Cart

Results from the 2023 ASHP National Survey of Hospital Pharmacy Practice: Key Trends in Health-System Pharmacy Practice

ACPE Activity Number: 0204-0000-24-530-H04-P/T
Release Date:  6/18/2024
Expiration Date: 6/18/2027 
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEU)
Activity Fee: Free 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

The authors of the 2023 National Survey will present top line and detailed data from the survey, highlighting and analyzing meaningful findings on current health-system pharmacy practice and trends likely to impact practice in the future. The 2023 survey evaluated pharmacy operations, the adoption and utilization of pharmacy technologies, and progress on practice advancement initiatives. The survey also measured how health systems are addressing the challenges of current hot topics in pharmacy.

ACPE Provider with Commendation logo

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This continuing pharmacy education activity is designed for pharmacy leaders and hospital administrators.  

After participating in this CPE activity, participants should be able to:

1. Describe trends in hospital pharmacy practice, including characteristics related to drug distribution, pharmacy operations, and technology.
2. Discuss survey results related to current issues in hospital pharmacy practice.
3. Identify gaps in survey results that affect the adoption of best practices or PAI 2030 recommendations.

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

• Michael Ganio, PharmD, MS, FASHP, Senior Director, Pharmacy Practice and Quality, ASHP Center on Medication Safety and Quality
• Craig Pedersen, PhD, RPh, FAPhA, FASHP, Pharmacy Manager, Virginia Mason Franciscan Health, Clinical Professor, University of Washington
• Philip Schneider, MS, FASHP, FASPEN, FFIP, Professor, College of Pharmacy, The Ohio State University

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity. 

 

Provided by ASHP
Supported in part by an educational grant from Merck